CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it will provide an overview of its drug discovery and development programs targeted to Toll-like Receptors and a general corporate update at the 17th Annual NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010 at 2:30 p.m. ET at the Millennium Broadway Hotel & Conference Center in New York City.
